Skip to main content
PLOS One logoLink to PLOS One
. 2024 Jul 12;19(7):e0305033. doi: 10.1371/journal.pone.0305033

Moderation by better sleep of the association among childhood maltreatment, neuroticism, and depressive symptoms in the adult volunteers: A moderated mediation model

Jiro Masuya 1,*, Chihiro Morishita 1, Miki Ono 1, Mina Honyashiki 1, Yu Tamada 1, Tomoteru Seki 1, Akiyoshi Shimura 1, Hajime Tanabe 2, Takeshi Inoue 1
Editor: Anthony A Olashore3
PMCID: PMC11244762  PMID: 38995961

Abstract

Background

Previously, we demonstrated that childhood maltreatment could worsen depressive symptoms through neuroticism. On the one hand, some studies report that sleep disturbances are related to childhood maltreatment and neuroticism and worsens depressive symptoms. But, to our knowledge, no reports to date have shown the interrelatedness between childhood maltreatment, neuroticism, and depressive symptoms, and sleep disturbance in the one model. We hypothesized that sleep disturbance enhances the influence of maltreatment victimization in childhood or neuroticism on adulthood depressive symptoms and the mediation influence of neuroticism between maltreatment victimization in childhood and adulthood depressive symptoms.

Subjects and methods

Total 584 Japanese volunteer adults recruited through convenience sampling from 4/2017 to 4/2018 were assessed regarding their characteristics of demographics, history of childhood maltreatment, sleep disturbance, neuroticism, and depressive symptoms with questionnaires self-administered. Survey data were analyzed using simple moderation models and a moderating mediation model.

Results

The interaction of sleep disturbance with childhood maltreatment or neuroticism on depressive symptoms was significantly positive. Furthermore, the moderating effect of sleep disturbance on the indirect effect of childhood maltreatment to depressive symptoms through neuroticism was significantly positive.

Limitations

Because this was a cross-sectional study, a causal relationship could not be confirmed.

Conclusions

Our findings indicate that individuals with milder sleep disturbance experience fewer depressive symptoms attributable to neuroticism and childhood maltreatment. Additionally, people with less sleep disturbance have fewer depressive symptoms arising from neuroticism owing to childhood maltreatment. Therefore, improvement of sleep disturbance will buffer the aggravating effect of childhood maltreatment, neuroticism caused by various factors, and neuroticism resulting from childhood maltreatment on depressive symptoms.

Introduction

It is widely accepted that childhood maltreatment (CM) is one of the risk factors for the onset or worsening of depressive symptoms in adults [1, 2]. Because of the time gap between the occurrence of CM and the development of adulthood depressive symptoms, there are assumed to be some mediators. Increasing lines of evidence demonstrate that psychological characteristics such as cognitive styles or personality characteristics, mediate the relationship between CM and adulthood depression [35]. We previously reported that CM might aggravate depressive symptoms through neuroticism in the general population [6]. A narrative review defined neuroticism as “the tendency to experience frequent, intense negative emotions associated with a sense of uncontrollability (the perception of inadequate coping) in response to stress”, with an underlying mechanism involving dynamic genetic and environmental interactions [7]. In addition, neuroticism is a risk factor for psychiatric problems, and has been specified as an essential risk factor for the development of major depressive disorder in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, revised in 2013 [8, 9].

Therefore, it is an important task to identify the negative influences of CM and neuroticism on adulthood depressive symptoms. Although few intervention studies have investigated treatments focusing on the aggravating influences of CM on adulthood depressive symptoms, Joss et al. reported that there was no group by time interaction between subjects with mindfulness-based intervention and a waiting list control group for changes of depressive symptoms in subjects who have experienced mild-to-moderate CM [10]. In contrast, many studies have reported that transdiagnostic cognitive behavioral therapy and paroxetine significantly improve neuroticism [11, 12]. Regarding observational studies, a recent prospective cohort study demonstrated that CM causes sleep disturbance, which results in the worsening of depressive symptoms, suggesting that the improvement of sleep disturbance may ameliorate the exacerbating effect of CM on adulthood depressive symptoms [13]. Additionally, we demonstrated that some personality traits interact with the influence of sleep disturbance on adulthood depressive symptoms. Our previous study showed that resilience, a personality trait that enables growth in the face of adversity, is the opposite of neuroticism and significantly alleviates sleep disturbances and depressive symptoms in adulthood [14, 15]. Furthermore, we showed that affective temperaments, a personality trait defined by Kraepelin as the fundamental state of manic-depressive illness and modified by Akiskal, significantly interact with the influence of sleep disturbance on adulthood depressive symptoms [16, 17].

But, to our knowledge, no study to date has researched the moderation effect of sleep for CM or neuroticism on adulthood depressive symptoms. Investigating this missing link would contribute to the treatment for depressive symptoms caused by CM and neuroticism. Therefore, we hypothesized the following: (1) sleep disturbance exacerbates the influence of CM on depressive symptoms, (2) sleep disturbance worsens the influence of neuroticism on depressive symptoms, and (3) better sleep reduces the mediation influence of neuroticism between CM and depressive symptoms. We tested these hypotheses by simple moderation analyses and a moderated mediation analysis.

Subjects and methods

Subjects

Total 1,237 Japanese non-clinical volunteer adults recruited through convenience sampling at Tokyo Medical University from 4/2017 to 4/2018. Self-completion questionnaires were distributed to all subjects. Participants had to be at least 20 years old and give written consent to participate. Exclusion conditions were the presence of serious physical or organic psychiatric illness. Furthermore, all subjects were informed that participation was voluntary, that there would be no disadvantages for non-participation, and that anonymity would be ensured. Total 597 participants provided informed consent and replied to the survey. We excluded 13 individuals with missing data and analyzed data from a 584 total. The subjects’ mean age was 41.7 ± 12.1 years, and 249 (42.6%) were male. This study was conducted in accordance with the Declaration of Helsinki (as amended in Fortaleza during 2013). It was also approved by the Institutional Review Board of Tokyo Medical University (research approval number: SH3502).

Questionnaires

Eysenck Personality Questionnaire-Revised (EPQ-R)

Neuroticism was assessed by the neuroticism subscale (12 items) of the shortened version of the EPQ-R, following the method of Kendler et al. [18, 19]. The reliability and validity of the Japanese short-scale version of the EPQ-R have been confirmed [20]. Each item is rated on a two-point scale. Higher total scores are interpreted as higher neuroticism.

Patient Health Questionnaire-9 (PHQ-9)

PHQ-9 is a self-completion questionnaire for the measuring the severity of depressive symptoms [21]. The Japanese version was developed, and its high reliability and validity have been verified [22]. PHQ-9 is composed of nine questions, each of which is assessed using a four-point Likert scale, with higher total scores indicating more severe depressive symptoms.

Child Abuse and Trauma Scale (CATS)

CATS is a self-completion questionnaire for evaluating abuse and related trauma in childhood [23]. The Japanese version was developed, and its high reliability and validity have been verified [24]. There are 3 subscales consisting of 38 items. The items were rated on a 5-point Likert scale from 0 to 4, and the total score was used for the analysis. Higher total scores are interpreted as indicating that the victimization of childhood abuse was more severe.

Pittsburgh Sleep Quality Index Japanese Version (PSQI-J)

Pittsburgh Sleep Quality Index (PSQI) is a self-administered questionnaire for assessing sleep disturbance, and its high reliability and validity have been verified [25]. PSQI is composed of seven subscales. Each subscale is scored on a scale of 0 to 3. A higher total score is interpreted as poorer sleep quality and more severer sleep disturbance [25]. PSQI was translated to the Japanese version (PSQI-J), and validated by back translation [26].

Data analysis

Pearson’s correlation analyses were performed to investigate associations among age, CATS total scores, EPQ-R scores, PHQ-9 scores, and PSQI-J total scores. Our previous study using the different sample from this study showed that (1) CATS scores significantly directly and indirectly positively predict increasing PHQ-9 scores via EPQ-R scores, and (2) EPQ-R scores significantly positively predict increasing PHQ-9 scores [6]. Therefore, this simple mediation analysis was not performed in the present study. Simple moderation analyses were performed to investigate the hypothesis that PSQI-J total scores moderate the effect of CATS total scores and EPQ-R scores on PHQ-9 scores. Finally, moderated mediation analysis was performed according to the hypothesis that PSQI-J total scores moderate the mediation effect of EPQ-R scores from CATS total scores to PHQ-9 total scores.

All analyses were performed with R version 4.1.2. software (R core team, Vienna, Austria), and PROCESS for R macro version 4.1 software was used for the simple moderation analyses (Model 1 in PROCESS) and the moderated mediation analysis (Model 15 in PROCESS) (Hayes., 2022). Variables used as the interaction terms were centralized before the analysis. 95% bias-corrected confidence intervals of the indirect effect, and the index of moderated mediation in the moderated mediation model were computed using bootstrapping methods (n = 2,000). An indirect effect was considered significant if the 95% confidence interval (95% CI) for the indirect effect did not contain 0. In addition, when the index of moderated mediation did not include 0, the moderated mediation was judged to be significant. Unstandardized partial coefficients rather than standardized partial coefficients were reported in this study, because PROCESS version 4.1 was not able to compute precise standardized partial coefficients of variables that are calculated using bootstrapping methods in moderated mediation analyses. All the analyses included age and sex as covariates. The statistical significance level was defined as a p-value of less than 0.05.

Results

Demographic information (Table 1)

Table 1. Demographic characteristics of the subjects.

Characteristic or measure Number or mean ± SD
Age (years) 41.7 ± 12.1
Sex (men: women) 249 (42.6%): 335 (57.4%)
Years of education 14.6 ± 1.8
Employment status
(employed: nonemployed)
555: 25
Current marital status
(married: single)
382: 197
Presence of offspring (yes: no) 365: 215
Living alone (yes: no) 112: 459
Past history of mental illness (yes: no) 68 (11.6%): 516 (88.4%)
Current mental illness (yes: no) 26: 548

Data are presented as means ± standard deviations (SD) or numbers.

Table 1 presents the demographic information of the 584 subjects.

Pearson’s correlation analysis (Table 2)

Table 2. Pearson’s correlation coefficients (r) among age, CATS total scores, EPQ-R scores, PHQ-9 scores, and PSQI-J total scores of the subjects.

Mean SD Age CATS EPQ-R PHQ-9 PSQI-J
Age 41.7 12.1
CATS 27.3 20.0 0.0727
EPQ-R 4.4 3.5 –0.196*** 0.225***
PHQ-9 4.1 4.2 0.0344 0.320*** 0.558***
PSQI-J 5.8 3.5 0.0315 0.213*** 0.321*** 0.566***

***p < 0.001

CATS, Child Abuse and Trauma Scale; EPQ-R, Eysenck Personality Questionnaire-Revised; PHQ-9, Patient Health Questionnaire-9; PSQI-J, Pittsburgh Sleep Quality Index Japanese Version; SD, standard deviation

The associations among age, CATS total scores, EPQ-R scores, PHQ-9 scores, and PSQI-J total scores are shown in Table 2. CATS total scores significantly and positively correlated with PHQ-9 scores, and PSQI-J total scores. EPQ-R scores significantly and positively correlated with CATS total scores, PHQ-9 scores, and PSQI-J total scores, whereas they significantly and negatively correlated with age. Additionally, PHQ-9 scores significantly and positively correlated with PSQI-J total scores.

Simple moderation analyses

Interaction of CATS total scores and PSQI-J total scores on PHQ-9 scores

CATS total scores, PSQI-J total scores, and the interaction term obtained by multiplying these 2 variables significantly and positively correlated with PHQ-9 scores (F [2,546] = 81.43, p < 0.001; CATS total score, unstandardized partial coefficient B = 0.044, p < 0001; PSQI-J global score, B = 0.626, p < 0.001; interaction term, B = 0.005, p = 0.015). The adjusted R2 was 0.376, indicating that 37.6% of the variance in PHQ-9 scores was accounted for by the model. The ΔR2 value, which indicates the difference of the R2 of the models with and without the interaction term, was significantly positive.

Interaction of EPQ-R scores and PSQI-J global scores on PHQ-9 scores

EPQ-R scores, PSQI-J global scores, and the interaction term obtained by multiplying the former 2 variables significantly and positively associated with PHQ-9 scores (F [2,548] = 126.26, p < 0.001; EPQ-R score, B = 0.478, p < 0001; PSQI-J global score, B = 0.503, p < 0.001; interaction term, B = 0.042, p < 0.001). The adjusted R2 was 0.481 and ΔR2 was significantly positive.

Moderated mediation analysis (Table 3 and Fig 1)

Table 3. Conditional indirect effects of CATS total scores on PHQ-9 scores through EPQ-R across levels of PSQI-J global scores.

Moderator (PSQI-J) levels Effect SE 95% CI (lower, upper)
Low (M– 1SD) 0.013 0.004 (0.007, 0.021)
Medium (M) 0.018 0.004 (0.011, 0.027)
High (M + 1SD) 0.024 0.006 (0.013, 0.035)

CATS, Child Abuse and Trauma Scale; EPQ-R, Eysenck Personality Questionnaire-Revised; PHQ-9, Patient Health Questionnaire-9; PSQI-J, Pittsburgh Sleep Quality Index Japanese Version; M, mean; SD, standard deviation, SE, standard error, CI, confidential interval.

Fig 1. Moderated mediation model of sleep disturbance, childhood maltreatment, neuroticism and depressive symptoms.

Fig 1

The dashed arrows indicate moderation effects. The numbers next to the arrows suggest unstandardized partial coefficients. CATS, Child Abuse and Trauma Scale; EPQ-R, Eysenck Personality Questionnaire-Revised; PHQ-9, Patient Health Questionnaire-9; PSQI-J, Pittsburgh Sleep Quality Index Japanese Version; CI, confidence interval.

Resuits of the moderated mediation analysis are presented in Fig 1 and Table 3. CATS scores were significantly positively associated with EPQ-R scores, and EPQ-R scores were significantly positively associated with PHQ-9 scores. The direct effect of CATS total scores on PHQ-9 scores was also significantly positive. Moreover, the interaction of PSQI-J global scores with CATS total scores and EPQ-R scores on PHQ-9 scores was significantly positive (Fig 1). In addition, the conditional indirect effects of CATS total scores via EPQ-R scores on PHQ-9 scores at 3 PSQI-J global scores (mean –1 standard deviation, mean, mean +1 standard deviation) were significantly positive, and the conditional indirect effects became higher as the PSQI-J global scores became higher (Table 3). In addition, the index of moderated mediation was positive significantly (Fig 1). The model was significant and the adjusted R2 was 0.514.

Discussion

We presented for the first time to our knowledge the significant interaction effects of sleep disturbance with CM and neuroticism on depressive symptoms in simple moderation models in this study. The moderated mediation model showed the significant moderation of sleep on the direct effects of CM and neuroticism on depressive symptoms, and the significant moderated mediation effect of CM on depressive symptoms via neuroticism, depending on the level of sleep disturbance. The present findings support our hypotheses. In other words, better sleep is associated with a smaller negative effect of CM or neuroticism on depressive symptoms, and a smaller aggravating mediation effect of CM on depressive symptoms through neuroticism.

Considering the results of the significant interaction of CM and sleep disturbance on depressive symptoms, an improvement of sleep could ameliorate the negative influence of CM on depressive symptoms. Sleep disturbance as a modifiable moderation factor is important because CM is not a factor that can be intervened in clinical practice for grown-ups. Sleep can be improved by treating sleep disorders or maintain sleep hygiene [27, 28]. Moreover, we showed the significant exacerbation of sleep disturbance on the direct effect of CM on depressive symptoms, suggesting that improving sleep can buffer the influence of CM on depressive symptoms by a pathway other than improving neuroticism. To our knowledge, there are no similar reports regarding the moderation effect of CM and sleep on adult mental health.

Regarding the results of the significant interaction of neuroticism and sleep disturbance on depressive symptoms, improvement of sleep disturbance could buffer the effect of neuroticism on depressive symptoms. Previously, Zhou et al. showed that chronotype and sleep quality significantly moderate the influence of resilience on depressive symptoms [29]. Moreover, we confirmed the significant interaction between resilience to depressive symptoms and sleep disturbances using the same subjects as in the present study [15]. As noted in the Introduction chapter, resilience appears to be an opposite personality trait to neuroticism [30], suggesting that the above findings in association with resilience support our present results. Additionally, our results suggest that improvement of neuroticism could ameliorate the worsening effect of sleep disturbance on depressive symptoms. As noted in the Introduction chapter, previous studies reported that transdiagnostic cognitive behavioral therapy and paroxetine are effective for neuroticism, suggesting that these interventions ameliorate the depressive symptoms caused by sleep disturbance [11, 12]. On the other hand, in a previous study, a 3-year prospective study reported that the presence of workplace harassment increased neuroticism, and the absence of workplace harassment reduced neuroticism. This indicates that the neuroticism are not immutable dispositions. This suggests that stressors such as workplace harassment may further exacerbate depressive symptoms caused by sleep disturbances [31].

Finally, in this study, we demonstrated that better sleep moderates the mediation effect of CM on depressive symptoms via neuroticism. Barlow et al. proposed the theory of the developmental origins of neuroticism, in which they assumed that synergistic psychological and biological vulnerabilities underlie neuroticism [7]. In other words, the etiologies of neuroticism are heterogeneous, suggesting that focusing on the neuroticism caused specifically by CM is methodologically necessary.

In this study, we showed the moderating role of sleep disturbance on the effect of CM and neuroticism on depressive symptoms, and the effect of CM on depressive symptoms through neuroticism. In a clinical setting, assessment of CM damage, neuroticism, and sleep disturbances, and interventions to ameliorate sleep disturbances, may be useful in treating depressive symptoms in subjects with the victimization of CM and neuroticism.

Limitations

There are several limitations to the present study. First, the subjects in this study were recruited using convenience sampling, which is not strict probability sampling. This reduces the randomness of subject selection, which may reduce the accuracy of the results by including potential bias. Second, we could not conclude the causal associations among CM, neuroticism, depressive symptoms, and sleep disturbance, because the present study was a cross-sectional study. Long-term prospective longitudinal studies are needed to confirm the causal associations between sleep disturbance and depressive symptoms. Third, subjects in this study were not confirmed to have depression or other psychiatric disorders. In addition, we did not investigate the presence or absence of an actual diagnosis of depression in the patients, as only a self-administered survey was used in this study. Therefore, the results of this study cannot be used as being associated with depression. Sleep disturbances are a well-known symptom of depression and a factor indicating the severity of depression. However, in the present study, we did not consider sleep disturbances as only a symptom of depression, but also as a risk factor for enhancing the effects of CM on depressive symptoms in adulthood, and the effects of neuroticism on depressive symptoms in adulthood [32, 33]. Fourth, in this study, sleep disturbances were assessed subjectively and future research should be based on objective data. Finally, recall bias may have affected the subjects’ history of CM.

Conclusion

To our best knowledge, this study is the first to study to date to report the moderation effect of better sleep on the effect of CM, neuroticism and the mediation effect of CM via neuroticism on depressive symptoms. These findings suggest the importance of intervening with sleep disturbance for the treatment for depressive symptoms in subjects with CM or neuroticism. More extensive prospective studies are necessary to clarify these points in the future.

Acknowledgments

We thank Dr. Nobutada Takahashi of Fuji Psychosomatic Rehabilitation Institute Hospital, Dr. Hiroshi Matsuda of Kashiwazaki Kosei Hospital, Dr. Yasuhiko Takita (deceased) of Maruyamasou Hospital, and Dr. Yoshihide Takaesu of Izumi Hospital for their collection of subject data. We thank Dr. Helena Popiel of the Center for International Education and Research, Tokyo Medical University, for editorial review of the manuscript.

Data Availability

Data cannot be shared publicly because of Ethics Committee restriction. All relevant data are within the paper. Data are available from the Internal Review Board of the Department of Psychiatry, Tokyo Medical University (Japan) (contact via email: seisinka@tokyo-med.ac.jp) for researchers who meet the criteria for access to confidential data.

Funding Statement

This work was partly supported by a Grant-in-Aid for Scientific Research (no. 21K07510, to TI) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (https://www.jsps.go.jp/english/egrants/). We have corrected the information in the revised manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Li M, D’Arcy C, Meng X. Maltreatment in childhood substantially increases the risk of adult depression and anxiety in prospective cohort studies: systematic review, meta-analysis, and proportional attributable fractions. Psychol. Med. 2016;46:717–730. doi: 10.1017/S0033291715002743 . [DOI] [PubMed] [Google Scholar]
  • 2.Nelson J, Klumparendt A, Doebler P, Ehring T. Childhood maltreatment and characteristics of adult depression: meta-analysis. Br. J. Psychiatry. 2017;210:96–104. doi: 10.1192/bjp.bp.115.180752 . [DOI] [PubMed] [Google Scholar]
  • 3.Hovens JG, Giltay EJ, van Hemert AM, Penninx BW. Childhood maltreatment and the course of depressive and anxiety disorders: the contribution of personality characteristics. Depress. Anxiety. 2016;33:27–34. doi: 10.1002/da.22429 . [DOI] [PubMed] [Google Scholar]
  • 4.Klumparendt A, Nelson J, Barenbrügge J, Ehring T. Associations between childhood maltreatment and adult depression: a mediation analysis. BMC Psychiatry. 2019; 19(1):36. doi: 10.1186/s12888-019-2016-8 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Tao J, He K, Xu J. The mediating effect of self-compassion on the relationship between childhood maltreatment and depression. J. Affect. Disord. 2021;291:288–293. doi: 10.1016/j.jad.2021.05.019 . [DOI] [PubMed] [Google Scholar]
  • 6.Ono K, Takaesu Y, Nakai Y, Shimura A, Ono Y, Murakoshi A, et al. Associations among depressive symptoms, childhood abuse, neuroticism, and adult stressful life events in the general adult population. Neuropsychiatr. Dis. Treat. 2017;13:477–482. doi: 10.2147/NDT.S128557 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Barlow DH, Ellard KK, Sauer-Zavala S, Bullis JR, Carl JR. The origins of neuroticism. Perspect. Psychol. Sci. 2014;9(5):481–496. doi: 10.1177/1745691614544528 . [DOI] [PubMed] [Google Scholar]
  • 8.Jeronimus BF, Kotov R, Riese H, Ormel J. Neuroticism’s prospective association with mental disorders halves after adjustment for baseline symptoms and psychiatric history, but the adjusted association hardly decays with time: a meta-analysis on 59 longitudinal/prospective studies with 443 313 participants. Psychol. Med. 2016;46(14):2883–2906. doi: 10.1017/S0033291716001653 . [DOI] [PubMed] [Google Scholar]
  • 9.American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5, 5th ed. American Psychiatric Association, Arlington, VA. 2013. [Google Scholar]
  • 10.Joss D, Khan A, Lazar SW, Teicher MH. Effects of a mindfulness-based intervention on self-compassion and psychological health among young adults with a history of childhood maltreatment. Front. Psychol. 2019;10: 2373. doi: 10.3389/fpsyg.2019.02373 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sauer-Zavala S, Fournier JC, Jarvi Steele S, Woods BK, Wang M, Farchione TJ, et al. Does the unified protocol really change neuroticism? Results from a randomized trial. Psychol. Med. 2021;51(14):2378–2387. doi: 10.1017/S0033291720000975 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Tang TZ, DeRubeis RJ, Hollon SD, Amsterdam J, Shelton R, Schalet B. Personality change during depression treatment: a placebo-controlled trial. Arch. Gen. Psychiatry. 2009;66(12):1322–1330. doi: 10.1001/archgenpsychiatry.2009.166 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Javakhishvili M, Spatz Widom C. Childhood maltreatment, sleep disturbances, and anxiety and depression: a prospective longitudinal investigation. J. Appl. Dev. Psychol. 2021;77:101351. doi: 10.1016/j.appdev.2021.101351 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress. Anxiety. 2003;18(2):76–82. doi: 10.1002/da.10113 . [DOI] [PubMed] [Google Scholar]
  • 15.Terao I, Masuya J, Morishita C, Higashiyama M, Shimura A, Tamada Y, et al. Resilience moderates the association of sleep disturbance and sleep reactivity with depressive symptoms in adult volunteers. Neuropsychiatr. Dis. Treat. 2022;18:1249–1257. doi: 10.2147/NDT.S361353 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.von Zerssen D, Akiskal HS. Personality factors in affective disorders: historical developments and current issues with special reference to the concepts of temperament and character. J. Affect. Disord. 1998;51:1–5. doi: 10.1016/s0165-0327(98)00151-7 . [DOI] [PubMed] [Google Scholar]
  • 17.Toyoshima K, Inoue T, Masuya J, Fujimura Y, Higashi S, Kusumi I. Affective temperaments moderate the effect of insomnia on depressive symptoms in adult community volunteers. J. Affect. Disord. 2021;282:726–731. doi: 10.1016/j.jad.2020.12.138 . [DOI] [PubMed] [Google Scholar]
  • 18.Eysenck SBG, Eysenck HJ, Barrett P. A revised version of the psychoticism scale. Pers. Individ. Dif. 1985;6(1):21–29. 10.1016/0191-8869(85)90026-1. [DOI] [Google Scholar]
  • 19.Kendler KS, Kuhn J, Prescott CA. The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. Am. J. Psychiatry. 2004;161(4):631–636. doi: 10.1176/appi.ajp.161.4.631 . [DOI] [PubMed] [Google Scholar]
  • 20.Nakai Y, Inoue T, Toyomaki A. A study of validation of the Japanese version of the shortened Eysenck Personality Questionnaire-Revised. Sapporo Japan. 2015. [Google Scholar]
  • 21.Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA. 1999;282(18):1737–1744. doi: 10.1001/jama.282.18.1737 . [DOI] [PubMed] [Google Scholar]
  • 22.Muramatsu K, Miyaoka H, Kamijima K, Muramatsu Y, Yoshida M, Otsubo T, et al. The patient health questionnaire, Japanese version: validity according to the mini-international neuropsychiatric interview-plus. Psychol Rep. 2007;101(3 Pt 1):952–960. doi: 10.2466/pr0.101.3.952-960 . [DOI] [PubMed] [Google Scholar]
  • 23.Sanders B, Becker-Lausen E. The measurement of psychological maltreatment: early data on the child abuse and trauma scale. Child Abuse Negl. 1995;19:315–323. doi: 10.1016/s0145-2134(94)00131-6 . [DOI] [PubMed] [Google Scholar]
  • 24.Tanabe H, Ozawa S, Goto K. Psychometric properties of the Japanese version of the Child Abuse and Trauma Scale (CATS). The 9th Annual Meeting of the Japanese Society for Traumatic Stress Studies: Kobe, Japan. 6 March, 2010. [Google Scholar]
  • 25.Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213. doi: 10.1016/0165-1781(89)90047-4 . [DOI] [PubMed] [Google Scholar]
  • 26.Doi Y, Minowa M, Okawa M, Uchiyama M. Development of the Japanese version of the Pittsburgh Sleep Quality Index (in Japanese). Jpn J Psychiatr Treat. 1998;13:755–763. [Google Scholar]
  • 27.Shimura A, Hideo S, Takaesu Y, Nomura R, Komada Y, Inoue T. Comprehensive assessment of the impact of life habits on sleep disturbance, chronotype, and daytime sleepiness among high-school students. Sleep Med. 2018;44:12–18. doi: 10.1016/j.sleep.2017.10.011 . [DOI] [PubMed] [Google Scholar]
  • 28.Shimura A, Sugiura K, Inoue M, Misaki S, Tanimoto Y, Oshima A, et al. Which sleep hygiene factors are important? comprehensive assessment of lifestyle habits and job environment on sleep among office workers. Sleep Health. 2020;6(3):288–298. doi: 10.1016/j.sleh.2020.02.001 . [DOI] [PubMed] [Google Scholar]
  • 29.Zhou J, Hsiao FC, Shi X, Yang J, Huang Y, Jiang Y, et al. Chronotype and depressive symptoms: a moderated mediation model of sleep quality and resilience in the 1st-year college students. J. Clin. Psychol. 2021;77:340–355. doi: 10.1002/jclp.23037 [DOI] [PubMed] [Google Scholar]
  • 30.Ito S, Morishita C, Masuya J, Ono M, Honyashiki M, Higashi S, et al. Moderating and Mediating Effects of Resilience Together with Neuroticism on Depressive Symptoms in Adult Volunteers. Neuropsychiatr. Dis. Treat. 2022;18:1751–1761. doi: 10.2147/NDT.S370201 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Persson R, Høgh A, Grynderup MB, Willert MV, Gullander M, Hansen ÅM, et al. Relationship between changes in workplace bullying status and the reporting of personality characteristics. J. Occup. Environ. Med. 2016;58(9):902–910. doi: 10.1097/JOM.0000000000000822 . [DOI] [PubMed] [Google Scholar]
  • 32.Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, et al. Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies. J. Affect. Disord. 2011;135:10–19. doi: 10.1016/j.jad.2011.01.011 . [DOI] [PubMed] [Google Scholar]
  • 33.Kalmbach DA, Arnedt JT, Song PX, Guille C, Sen S. Sleep disturbance and short sleep as risk factors for depression and perceived medical errors in first-year residents. Sleep. 2017;40(3):zsw073. doi: 10.1093/sleep/zsw073 . [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Anthony A Olashore

12 Feb 2024

PONE-D-23-24222

Moderation by better sleep of the association among childhood maltreatment, neuroticism, and depressive symptoms in the adult volunteers: a moderated mediation model

PLOS ONE

Dear Dr. Masuya,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 28 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Anthony A. Olashore, MBCHB, PhD, FWACP

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. 

Before we proceed with your manuscript, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see

https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible.

We will update your Data Availability statement on your behalf to reflect the information you provide.

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The study has groundbreaking potential on interventions designed for childhood trauma and depression.

1. Please go through the manuscript and revise grammar. some sentences are too long.

2. In my opinion, the authors should acknowledge limitations of using self-administered instruments in their limitations

3. As mentioned under limitations, sleep disturbance is a well researched and documented symptom of depression; there is however evidence suggesting it as a risk factor as well. The authors should justify why in this study they chose to consider it as a risk factor only and not account for it as a symptom signifying severity of depression.

Reviewer #2: This is a very good paper. The authors mentioned the mean age of participants; however, I suggest that authors include the sociodemographic characteristics of participants (add a table summarising this). This will help readers when they want to make decisions in evidence-based medicine. They can compare their clients or patients with the study population for similarity (external validity of the paper).

Maybe the authors could also add non-probability sampling as a limitation of the study.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: stephane tshitenge

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Jul 12;19(7):e0305033. doi: 10.1371/journal.pone.0305033.r002

Author response to Decision Letter 0


28 Apr 2024

REVIEWER #1

1. Please go through the manuscript and revise grammar. Some sentences are too long.

Response:

We thank you for your comments. In accordance with your suggestion, we have revised some sentences and asked a native English speaker experienced in proofreading scientific documents to recheck the paper.

2. In my opinion, the authors should acknowledge limitations of using self-administered instruments in their limitations

3. As mentioned under limitations, sleep disturbance is a well researched and documented symptom of depression; there is however evidence suggesting it as a risk factor as well. The authors should justify why in this study they chose to consider it as a risk factor only and not account for it as a symptom signifying severity of depression.

Response:

We thank you for your comments. In accordance with the comment, we have revised the limitations section of the revised manuscript, as follows.

“Third, subjects in this study were not confirmed to have depression or other psychiatric disorders. In addition, we did not investigate the presence or absence of an actual diagnosis of depression in the patients, as only a self-administered survey was used in this study. Therefore, the results of this study cannot be used as being associated with depression.” (page 19, lines 277 to 281)

“Sleep disturbances are a well-known symptom of depression and a factor indicating the severity of depression. However, in the present study, we did not consider sleep disturbances as only a symptom of depression, but also as a risk factor for enhancing the effects of CM on depressive symptoms in adulthood, and the effects of neuroticism on depressive symptoms in adulthood [32,33].” (page 19, lines 281 to 285)

REVIEWER #2

1. The authors mentioned the mean age of participants; however, I suggest that authors include the sociodemographic characteristics of participants (add a table summarising this). This will help readers when they want to make decisions in evidence-based medicine. They can compare their clients or patients with the study population for similarity (external validity of the paper).

Response:

We thank you for your comments. In accordance with your suggestion, we added a table with the demographic information of the 584 subjects, as Table 1 of the revised manuscript. (page 12, lines 173 to 174)

2. Maybe the authors could also add non-probability sampling as a limitation of the study.

Response:

We thank you for your comments. In accordance with the comments, we have revised the limitations section, as follows.

“First, the subjects in this study were recruited using convenience sampling, which is not strict probability sampling. This reduces the randomness of subject selection, which may reduce the accuracy of the results by including potential bias.” (page 19, lines 271 to 274)

Attachment

Submitted filename: [PONE-D-24222]_Response to Reviewers_28_Apr_2024.docx

pone.0305033.s001.docx (21KB, docx)

Decision Letter 1

Anthony A Olashore

23 May 2024

Moderation by better sleep of the association among childhood maltreatment, neuroticism, and depressive symptoms in the adult volunteers: a moderated mediation model

PONE-D-23-24222R1

Dear Dr. Masuya,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Anthony A. Olashore, MD, PhD.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Acceptance letter

Anthony A Olashore

28 May 2024

PONE-D-23-24222R1

PLOS ONE

Dear Dr. Masuya,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Anthony A. Olashore

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: [PONE-D-24222]_Response to Reviewers_28_Apr_2024.docx

    pone.0305033.s001.docx (21KB, docx)

    Data Availability Statement

    Data cannot be shared publicly because of Ethics Committee restriction. All relevant data are within the paper. Data are available from the Internal Review Board of the Department of Psychiatry, Tokyo Medical University (Japan) (contact via email: seisinka@tokyo-med.ac.jp) for researchers who meet the criteria for access to confidential data.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES